EPISODE · Feb 7, 2022 · 30 MIN
Annual Diabetes Update
from CEimpact Podcast · host CEimpact
Every January, the American Diabetes Association updates the Standards of Medical Care in Diabetes. The guidelines cover updates from diabetes advocacy to technology changes. Learn what changed and what matters most for individuals with diabetes.Time in range was introduced in the 2021 update and is becoming the standard of glycemic targets and control Metformin may not be the first line option for type 2 diabetes – comorbid conditions and cost to the patient should be considered when determining appropriate treatment More data is emerging suggesting the SGLT-2 inhibitors slow progression of diabetic neuropathy, CKD, and other comorbid conditions GLP-1 drugs may also aid in neuropathyIn older adults with diabetes, the upper threshold of A1c goal of 8.5% may not be as global as originally thought – glycemic targets should be matched with patient status and factors 00:00 – Introductions03:25 – Improving Care and Promoting Health06:07 – Classification of Diabetes07:55 – Prevention of Diabetes10:02 – Comprehensive Medication Evaluation 12:05 – Facilitating Behavior Changes14:14 – Glycemic Targets & DM Technology 17:08 – Obesity 18:15 – Pharmacologic Approach 24:00 – Cardiovascular Disease25:26 – Chronic Kidney Disease Management26:06 – Retinopathy, Neuropathy, & Foot Care28:15 – Diabetes in Older Adults29:38 – Closing Remarks John (Jake) A. Galdo, PharmD, MBA, BCPS, BCGP Course Content and Developer, CEimpact Pharmacist, Ross Bridge Pharmacy CEO, Seguridad, IncDr. Galdo received his Doctor of Pharmacy and completed PGY-1 Community Pharmacy Residency training from the University of Georgia, earned a Master of Business Administration from Samford University, and is board certified in both pharmacotherapy and geriatrics. Jake Galdo helps lead content and course development at CEimpact. Links to Resources:Standards of Medical Care in Diabetes-2022Take a deeper dive into glycemic management with Sue Cornell, BS, Pharm.D, CDCES, FAPhA, FADCES: CEimpactDr. Cornell currently serves as the associate director of experiential education and professor in the department of pharmacy practice at Midwestern University College of Pharmacy in Downers Gove, Illinois. She is also a certified diabetes care and education specialist. How to Claim CE: · Pharmacist· CMENeed a membership?Join for CPE Credit Join for CME Credit Continuing Education Information:Learning Objectives: Describe changes to the type 2 diabetes treatment algorithm based on the 2022 guidelinesIdentify appropriate first-line therapy for persons with diabetes and cardiovascular diseaseDr. Wall is a member of the Janssen Speaker's Bureau. Dr. Galdo reports no actual or potential conflicts of interest associated with this episode.0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-22-071-H01-PInitial release date: 02/07/22Expiration date: 02/07/23Additional CPE & CMFollow CEimpact on Social Media:LinkedInInstagram
NOW PLAYING
Annual Diabetes Update
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m